These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 9674869)

  • 21. Early viral complications after autologous CD34-selected peripheral blood stem cell transplantation.
    Sica S; Sora F; Chiusolo P; Laurenti L; Cattani P; Giordano G; Piccirillo N; Ortu La Barbera E; Leone G
    Bone Marrow Transplant; 2000 Sep; 26(5):587-8. PubMed ID: 11019854
    [No Abstract]   [Full Text] [Related]  

  • 22. Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children.
    Handgretinger R; Klingebiel T; Lang P; Schumm M; Neu S; Geiselhart A; Bader P; Schlegel PG; Greil J; Stachel D; Herzog RJ; Niethammer D
    Bone Marrow Transplant; 2001 Apr; 27(8):777-83. PubMed ID: 11477433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term immune recovery after CD34+ immunoselected and unselected peripheral blood progenitor cell transplantation: a case-control study.
    Laurenti L; Sica S; Sorà F; Piccirillo N; Ortu La Barbera E; Chiusolo P; Salutari P; Rumi C; Rutella S; Leone G
    Haematologica; 1999 Dec; 84(12):1100-3. PubMed ID: 10586212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Counterflow centrifugation allows addition of appropriate numbers of T cells to allogeneic marrow and blood stem cell grafts to prevent severe GVHD without substantial loss of mature and immature progenitor cells.
    Preijers FW; van Hennik PB; Schattenberg A; Ruijs P; Ploemacher RE; de Witte T
    Bone Marrow Transplant; 1999 May; 23(10):1061-70. PubMed ID: 10373074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe infections after allogeneic peripheral blood stem cell transplantation: a matched-pair comparison of unmanipulated and CD34+ cell-selected transplantation.
    Martino R; Rovira M; Carreras E; Solano C; Jorge S; De La Rubia J; Caballero MD; de Oteyza JP; Zuazu J; Moraleda JM; Ojeda E; Ferrá C; Serrano D; De La Cámara R; Urbano-Ispízua A; Brunet S;
    Haematologica; 2001 Oct; 86(10):1075-86. PubMed ID: 11602414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of two immunomagnetic separation technologies to deplete T cells from human blood samples.
    Lara O; Tong X; Zborowski M; Farag SS; Chalmers JJ
    Biotechnol Bioeng; 2006 May; 94(1):66-80. PubMed ID: 16518837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased incidence of EBV-associated lymphoproliferative disorders after allogeneic stem cell transplantation from matched unrelated donors due to a change of T cell depletion technique.
    Meijer E; Slaper-Cortenbach IC; Thijsen SF; Dekker AW; Verdonck LF
    Bone Marrow Transplant; 2002 Feb; 29(4):335-9. PubMed ID: 11896431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analysis of phenotypes and kinetics of CD34+ cells and lymphocytes in donors of hematopoietic stem cells for allogenic transplantation].
    Klabusay M; Suková V; Korístek Z; Mayer J; Vorlícek J
    Cas Lek Cesk; 2003; 142(7):410-6. PubMed ID: 14515444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Number of viable CD34(+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation.
    Allan DS; Keeney M; Howson-Jan K; Popma J; Weir K; Bhatia M; Sutherland DR; Chin-Yee IH
    Bone Marrow Transplant; 2002 Jun; 29(12):967-72. PubMed ID: 12098064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
    Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
    Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement of tumor cell depletion by combining immunomagnetic positive selection of CD34-positive hematopoietic stem cells and negative selection (purging) of tumor cells.
    Hoppe B; Mohr M; Roots-Weiss A; Kienast J; Berdel WE
    Bone Marrow Transplant; 1999 Apr; 23(8):809-17. PubMed ID: 10231144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical utility in maximizing CD34+ cell count in stem cell grafts.
    Burt RK
    Stem Cells; 1999; 17(6):373-6. PubMed ID: 10606166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mid-trimester fetal livers are a rich source of CD34+/++ cells for transplantation.
    Golfier F; Bárcena A; Cruz J; Harrison M; Muench M
    Bone Marrow Transplant; 1999 Sep; 24(5):451-61. PubMed ID: 10482927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigen-specific immunity following hematopoietic stem cell transplantation.
    Parkman R
    Blood Cells Mol Dis; 2008; 40(1):91-3. PubMed ID: 17870618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful cryopreservation of purified autologous CD34+ cells: influence of freezing parameters on cell recovery and engraftment.
    Beaujean F; Bourhis JH; Bayle C; Jouault H; Divine M; Rieux C; Janvier M; Le Forestier C; Pico JL
    Bone Marrow Transplant; 1998 Dec; 22(11):1091-6. PubMed ID: 9877272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does T-cell depletion have a future in allogeneic stem cell transplantation?
    de Witte TM
    Leuk Res; 2008 Sep; 32(9):1354-5. PubMed ID: 18346785
    [No Abstract]   [Full Text] [Related]  

  • 37. CD8+ cell depletion of donor lymphocyte infusions using cd8 monoclonal antibody-coated high-density microparticles (CD8-HDM) after allogeneic hematopoietic stem cell transplantation: a pilot study.
    Alyea EP; Canning C; Neuberg D; Daley H; Houde H; Giralt S; Champlin R; Atkinson K; Soiffer RJ
    Bone Marrow Transplant; 2004 Jul; 34(2):123-8. PubMed ID: 15133487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo engraftment potential of clinical hematopoietic grafts.
    Leung W; Ramírez M; Novelli EM; Civin CI
    J Investig Med; 1998 Aug; 46(6):303-11. PubMed ID: 9737093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of natural killer-cell depletion on ex vivo expansion of hematopoietic progenitor cells from umbilical cord blood.
    Sun R; Wei H; Zhang J; Tian Z
    Haematologica; 2003 May; 88(5):561-9. PubMed ID: 12745276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological individuality and the new frontiers of immunological tolerance in hematopoietic stem cell transplantation.
    Burgio GR; Zecca M; Comoli P; Maccario R
    Haematologica; 2010 Sep; 95(9):1447-51. PubMed ID: 20807985
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.